Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Low-Cost Technique Detects Rotavirus

By LabMedica International staff writers
Posted on 22 Oct 2014
A new measurement method that increases the capacity to detect biological substances such as Rotavirus using optical biosensors has been discovered and patented. More...


The system will enhance the detection capacity of small concentrations of Rotavirus due to a new way to assess the biosensing response applied to an interferometric device allowing the detection of both the presence of the virus and its antibody.

Scientists at the Universidad Politécnica de Madrid (Spain) have focused their interests on label-free optical biosensors that do not require the presence of enzymes that fix either the substance to be detected or the marker responsible for any detectable physical phenomenon. These biosensors consist of smooth or micro-nano textured surfaces made with a polymer whose surface has been chemically treated to be similar to a bioreceptor.

Once the surface is coated by the bioreceptor, the biosensor is sensitive and selective to a determined type of biomolecule. When the substance to detect is recognized by a bioreceptor this substance produces a change on its optical response or transduction. This change is usually the movement of the maximum or minimum position of the interferometric pattern. An easy interferometric system based on two Fabry Perot interferometers was tested. One interferometer is used as a reference and the other one captures the substance or virus. Besides, different options of data are analyzed as an alternative to the traditional position shift of the endpoints. This system is easy to install in compact devices and can be used by non-expert users.

The investigators have proved that by using transduction as a variable, the variation of emitted overall intensity at intervals of specific wave length, the sensitivity and detection limit of these biosensors can be significantly improved. All this can reach truly competitive levels for such a simple design. By using the proposed device and reading procedure, they could detect the presence of anti-Rotavirus in blood plasma or anti-Rotavirus as water contaminant. Due to its low cost compared to other methods such as enzyme-linked immunosorbent assay, this technique constitutes a promising way to reduce child mortality in developing countries.

Related Links:

Universidad Politécnica de Madrid



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.